CSF2 and familial pancreatic carcinoma: In order to study how the TME is altered by immunotherapy, Lutz et al. compared an irradiated, GM-CSF-secreting, allogeneic pancreatic cancer vaccine (GVAX) given as a single agent or in combination with low-dose cyclophosphamide to deplete Treg in the patients of pancreatic cancer.